Mociu Stelian-Ilie, Nedelcu Andreea-Dalila, Lupu Andreea-Alexandra, Uzun Andreea-Bianca, Iliescu Dan-Marcel, Ionescu Elena-Valentina, Iliescu Madalina-Gabriela
Faculty of Medicine, Doctoral School, "Ovidius" University of Constanta, 900470 Constanta, Romania.
Department of Physical Medicine and Rehabilitation, Balneal and Rehabilitation Sanatorium of Techirghiol, Techirghiol, 906100 Constanta, Romania.
Medicina (Kaunas). 2025 Sep 2;61(9):1588. doi: 10.3390/medicina61091588.
: Chronic low back pain markedly impairs quality of life and imposes a significant economic burden on public health. The complex pathophysiology of chronic low back pain arises from the complex anatomical configuration of the lumbar region, which includes a diverse array of structures. Consequently, etiologies may involve intervertebral disc degeneration, facet joint osteoarthritis, spinal stenosis, spondylosis, and spondylolisthesis. Therapeutic interventions for chronic low back pain are equally varied, ranging from pharmacological treatments to physiotherapy, kinetotherapy, balneotherapy, and image-guided local injectable procedures such as prolotherapy. Prolotherapy is a regenerative injection technique designed to stimulate the body's healing processes by applying a regenerative treatment (typically dextrose), which aims to modulate neurogenic inflammation and diminish nociceptive signaling. : A systematic review of the literature was performed in alignment with the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Studies published within the last ten years evaluating the effects of prolotherapy on pain reduction in individuals with chronic low back pain were included, following a search across six databases. Results: The review revealed several studies evaluating the influence of prolotherapy on pain in chronic low back pain patients. Findings were heterogeneous, with some studies indicating significant pain reduction and others showing minimal or no improvement. : The current evidence regarding the efficacy of prolotherapy for pain relief in chronic low back pain remains inconclusive, highlighting the necessity for further in-depth research. Continued and updated investigations into prolotherapy's role are imperative for enhancing the quality of life of affected patients.
慢性下腰痛显著损害生活质量,并给公共卫生带来巨大经济负担。慢性下腰痛复杂的病理生理学源于腰椎区域复杂的解剖结构,该区域包含多种不同结构。因此,病因可能涉及椎间盘退变、小关节骨关节炎、椎管狭窄、脊椎关节强硬和脊椎滑脱。慢性下腰痛的治疗干预同样多样,从药物治疗到物理治疗、运动疗法、浴疗法以及影像引导下的局部注射治疗如注射增殖疗法。注射增殖疗法是一种再生注射技术,旨在通过应用再生治疗(通常为葡萄糖)刺激身体的愈合过程,其目的是调节神经源性炎症并减少伤害性信号传导。
按照PRISMA指南(系统评价和Meta分析的首选报告项目)对文献进行了系统评价。在对六个数据库进行检索后,纳入了过去十年内发表的评估注射增殖疗法对慢性下腰痛患者疼痛减轻效果的研究。结果:该评价揭示了几项评估注射增殖疗法对慢性下腰痛患者疼痛影响的研究。研究结果存在异质性,一些研究表明疼痛显著减轻,而另一些研究则显示改善甚微或没有改善。
关于注射增殖疗法缓解慢性下腰痛疼痛效果的现有证据仍然不明确,这凸显了进一步深入研究的必要性。持续和更新对注射增殖疗法作用的调查对于提高受影响患者的生活质量至关重要。